copper sulfate has been researched along with lysophosphatidylcholines in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (50.00) | 18.2507 |
| 2000's | 2 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Inoue, I; Katahira, T; Katayama, S; Komoda, T; Kuwae, T; Nagata, A; Nakajima, T; Nakamura, H; Sakagishi, Y; Takahashi, K | 1 |
| Angel, A; Choy, PC; Choy, S; Dembinski, TC; Hatch, GM; Liu, SY; Lu, X; Man, RY; Mymin, D; Shen, X | 1 |
| Alderson, NL; Baynes, JW; Januszewski, AS; Jenkins, AJ; Thorpe, SR | 1 |
| Devaraj, H; Devaraj, NS; Rajasekaran, NS; Sathyanarayanan, S | 1 |
4 other study(ies) available for copper sulfate and lysophosphatidylcholines
| Article | Year |
|---|---|
Characterization of a specific monoclonal antibody 9F5-3a and the development of assay system for oxidized HDL.
Topics: Animals; Antibodies, Monoclonal; Arteriosclerosis; Copper; Copper Sulfate; Lipoproteins, HDL; Lipoproteins, LDL; Lysophosphatidylcholines; Mice; Mice, Inbred BALB C; Oxidation-Reduction | 1995 |
Alteration of lysophosphatidylcholine content in low density lipoprotein after oxidative modification: relationship to endothelium dependent relaxation.
Topics: Acetylcholine; Animals; Aorta; Copper; Copper Sulfate; Electrophoresis; Endothelium, Vascular; Humans; In Vitro Techniques; Lipid Peroxidation; Lipoproteins, LDL; Lysophosphatidylcholines; Nitric Oxide; Phenylephrine; Rats; Rats, Sprague-Dawley | 1994 |
Chemical modification of proteins during peroxidation of phospholipids.
Topics: Adult; Blood Proteins; Catalysis; Copper Sulfate; Diabetes Mellitus, Type 1; Dicarboxylic Acids; Female; Glutarates; Glycation End Products, Advanced; Humans; Lipid Peroxidation; Lipoproteins, LDL; Lysine; Lysophosphatidylcholines; Male; Oxidation-Reduction; Phospholipids; Ribonuclease, Pancreatic | 2005 |
Chronic depletion of glutathione (GSH) and minimal modification of LDL in vivo: its prevention by glutathione mono ester (GME) therapy.
Topics: Animals; Apolipoproteins B; Ascorbic Acid; Buthionine Sulfoximine; Cholesterol; Cholesterol, LDL; Copper Sulfate; Electrophoresis, Agar Gel; Electrophoretic Mobility Shift Assay; Enzyme Inhibitors; Glutathione; Lipoproteins, LDL; Lysophosphatidylcholines; Male; Malondialdehyde; Oxidation-Reduction; Oxidative Stress; Phosphatidylcholines; Rats; Rats, Wistar; Vitamin E | 2005 |